New Hampshire has postponed a pending trial against drugmaker Johnson & Johnson over opioid distribution and marketing from February to September because of COVID-19 concerns.
The state of New Hampshire was scheduled to face a jury trial on Feb. 2 against Johnson & Johnson and Janssen Pharmaceuticals, Inc.
Eight weeks were allotted for the trial in Merrimack County Superior Court, but lawyers and the judge brought up concerns Friday about delays and too few jury members if participants test positive for the COVID-19 virus.
Jury selection is expected to be held after Labor Day.
Copyright 2025 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Was this article valuable?
Here are more articles you may enjoy.
Applied Systems, Comulate Spar Over Trade Secret Theft Allegations 
Viewpoint: Healthcare Cyber Insurance at an Inflection Point 
In Alabama, Shot Employee Gets No Workers’ Comp and No Employer’s Liability 
One of Highest Property Claims Severity Recorded in Q3 on Low Volume, Says Verisk 
